1262870-13-2

Upstream product

• 1262870-12-1 (4bS,8aS,9S)-benzyl 3-(benzyloxy)-2-nitro-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene-11-carboxylate 
• 1262870-32-5 C₁₆H₂₀N₂O₃ 
• 1262870-04-1 (4bS,8aS,9S)-benzyl 3-hydroxy-2-nitro-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene-11-carboxylate 
• 159723-96-3 N-17-Cbz-3-hydroxymorphinan 
• 501-53-1 benzyl chloroformate 
• 15676-23-0 (+)-3-Hydroxymorphinan 

Downstream Products

• 1262870-16-5 (+)-3-benzyloxy-2-(2-cyanophenylamino)-N-(benzyloxycarbonyl)morphinan 
• 1262870-14-3 (4bS,8aS,9S)-benzyl 3-(benzyloxy)-2-((2-nitrophenyl)amino)-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene-11-carboxylate 
• 1262870-17-6 (+)-3-benzyloxy-2-(2-(methoxycarbonyl)phenylamino)-N-(benzyloxycarbonyl)morphinan 
• 1262869-27-1 (+)-2-(2-aminophenylamino)-3-hydroxymorphinan trifluoroacetate 
• 1262869-29-3 (+)-2-(2-cyanophenylamino)-3-hydroxymorphinan trifluoroacetate 
• 1262869-31-7 (+)-3-hydroxy-2-(2-(methoxycarbonyl)phenylamino)morphinan trifluoroacetate 
• 1262869-35-1 (+)-3-hydroxy-2-(2-(methanesulfonamido)phenylamino)morphinan trifluoroacetate 
• 1262869-67-9 (+)-2-(2-(dimethylamino)phenylamino)-3-hydroxymorphinan trifluoroacetate 
• 1262869-79-3 (+)-1-bromo-3-hydroxy-2-(2-(methanesulfonamido)phenylamino)morphinan trifluoroacetate 
• 1262869-83-9 (+)-3-hydroxy-2-(2-(methanesulfonamido)phenylamino)-1-methylmorphinan trifluoroacetate 
• 1262870-15-4 (+)-2-(2-aminophenylamino)-3-benzyloxy-N-(benzyloxycarbonyl)morphinan 
• 1262870-18-7 (+)-3-benzyloxy-2-(2-(methanesulfonamido)phenylamino)-N-(benzyloxycarbonyl)morphinan 
• 1262870-22-3 (+)-3-benzyloxy-2-(2-nitrophenyl(tert-butyloxylcarbonyl)amino)-N-(benzyloxycarbonyl)morphinan 
• 1262870-24-5 (+)-(2-aminophenyl(tert-butyloxylcarbonyl)amino)-3-benzyloxy-N-(benzyloxycarbonyl)morphinan 

Relevant academic research and scientific papers

(+)-3-HYDROXYMORPHINAN-BASED POLYCYCLE DERIVATIVES AS NEUROPROTECTANTS

A (+)-3-hydroxymorphinan-based polycycle derivative of formula (I) is effective as a neuroprotective agent for neurodegenerative diseases including Alzheimer's disease, Parkinson's disease, Huntington's disease, amyotrophic lateral sclerosis, and ischemic

(+)-3-HYDROXYMORPHINAN DERIVATIVES AS NEUROPROTECTANTS

A novel (+)-3-hydroxymorphinan derivatives and a pharmaceutical composition comprising the same as an active ingredient, which are useful for preventing or treating a neurodegenerative disease, are provided.